Yesi Shi

1.3k total citations · 1 hit paper
23 papers, 958 citations indexed

About

Yesi Shi is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Yesi Shi has authored 23 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Biomedical Engineering and 5 papers in Immunology. Recurrent topics in Yesi Shi's work include Nanoplatforms for cancer theranostics (12 papers), RNA Interference and Gene Delivery (8 papers) and Extracellular vesicles in disease (6 papers). Yesi Shi is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), RNA Interference and Gene Delivery (8 papers) and Extracellular vesicles in disease (6 papers). Yesi Shi collaborates with scholars based in China, United States and Taiwan. Yesi Shi's co-authors include Gang Liu, Yang Zhang, Chengchao Chu, En Ren, Gan Lin, Xin Pang, Xiaohong Chen, Wei Tao, Wei Chen and Seyoung Koo and has published in prestigious journals such as Chemical Reviews, Nature Communications and ACS Nano.

In The Last Decade

Yesi Shi

22 papers receiving 951 citations

Hit Papers

Chemically Modified Platforms for Better RNA Therapeutics 2024 2026 2025 2024 20 40 60

Peers

Yesi Shi
Jueun Jeon South Korea
Sol Shin South Korea
Yun Yang China
Jueun Jeon South Korea
Yesi Shi
Citations per year, relative to Yesi Shi Yesi Shi (= 1×) peers Jueun Jeon

Countries citing papers authored by Yesi Shi

Since Specialization
Citations

This map shows the geographic impact of Yesi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yesi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yesi Shi more than expected).

Fields of papers citing papers by Yesi Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yesi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yesi Shi. The network helps show where Yesi Shi may publish in the future.

Co-authorship network of co-authors of Yesi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yesi Shi. A scholar is included among the top collaborators of Yesi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yesi Shi. Yesi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yesi, Di Hu, Duyang Gao, et al.. (2025). Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy. Nature Nanotechnology. 21(1). 125–139.
2.
Jiang, Aijun, Pan He, Qian Zhang, et al.. (2024). Intelligent Generic High‐Throughput Oscillatory Shear Technology Fabricates Programmable Microrobots for Real‐Time Visual Guidance During Embolization. Small. 21(4). e2408613–e2408613. 2 indexed citations
3.
Zhang, Yiming, Yesi Shi, Fan Xiao, et al.. (2024). Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases. Trends in biotechnology. 42(11). 1439–1452. 11 indexed citations
4.
Chen, Shuying, Xiangang Huang, Yonger Xue, et al.. (2023). Nanotechnology-based mRNA vaccines. Nature Reviews Methods Primers. 3(1). 98 indexed citations
5.
Xu, Xiao, Hu Chen, Yangjie Wang, et al.. (2023). Engineering Radioactive Microspheres for Intra‐Arterial Brachytherapy Using Radiation‐Induced Graft Polymerization. Advanced Functional Materials. 33(50). 12 indexed citations
6.
Xue, Yi, Xiaoliu Liang, Pan He, et al.. (2023). Super‐Stable Homogeneously Sustained‐Release System Mediates Transcatheter Arterial Ionic‐Embolization Strategy for Hepatocellular Carcinoma Therapy. Advanced Functional Materials. 34(11). 6 indexed citations
7.
Chen, Hu, Pengfei Zhang, Yesi Shi, et al.. (2022). Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy. Journal of Nanobiotechnology. 20(1). 61–61. 28 indexed citations
8.
Mu, Dan, Pan He, Yesi Shi, Lai Jiang, & Gang Liu. (2022). Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor Immunotherapy. Frontiers in Oncology. 11. 819817–819817. 6 indexed citations
9.
Liu, Yuan, Hongyan Qian, Yesi Shi, et al.. (2022). Regulatory Fibroblast‐Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis. Advanced Science. 10(4). e2204998–e2204998. 38 indexed citations
10.
Shi, Yesi, Gan Lin, Huili Zheng, et al.. (2021). Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly. Journal of Nanobiotechnology. 19(1). 447–447. 27 indexed citations
11.
Shi, Yesi, Hongyan Qian, Dan Mu, et al.. (2021). Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases. Acta Pharmaceutica Sinica B. 12(3). 1126–1147. 21 indexed citations
12.
Bai, Shuang, Zhixiang Lu, Xiaoxiao Shi, et al.. (2021). Nanotransferrin-Based Programmable Catalysis Mediates Three-Pronged Induction of Oxidative Stress to Enhance Cancer Immunotherapy. ACS Nano. 16(1). 997–1012. 86 indexed citations
13.
Lu, Zhixiang, Shuang Bai, Yesi Shi, et al.. (2021). Artificial nanocage-based 3D framework platforms: From construction design to biomedical applications. Chemical Engineering Journal. 426. 131891–131891. 9 indexed citations
14.
Zhang, Yang, Xiaoyong Wang, Chengchao Chu, et al.. (2020). Genetically engineered magnetic nanocages for cancer magneto-catalytic theranostics. Nature Communications. 11(1). 5421–5421. 122 indexed citations
15.
Zheng, Huili, Yesi Shi, Qixuan Dai, et al.. (2020). Tumor microenvironment-triggered MoS2@GA-Fe nanoreactor: A self-rolling enhanced chemodynamic therapy and hydrogen sulfide treatment for hepatocellular carcinoma. Chemical Engineering Journal. 406. 126888–126888. 57 indexed citations
16.
Shi, Yesi, Fengfei Xie, Hongyan Qian, et al.. (2020). TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. Journal of Controlled Release. 320. 304–313. 85 indexed citations
17.
Shi, Yesi, Junqing Wang, Jingyi Liu, et al.. (2019). Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer. Biomaterials. 233. 119753–119753. 38 indexed citations
18.
Zhu, Jing, Chengchao Chu, Dongsheng Li, et al.. (2019). Fe(III)‐Porphyrin Sonotheranostics: A Green Triple‐Regulated ROS Generation Nanoplatform for Enhanced Cancer Imaging and Therapy. Advanced Functional Materials. 29(36). 141 indexed citations
19.
Lin, Gan, Yang Zhang, Congqing Zhu, et al.. (2018). Photo-excitable hybrid nanocomposites for image-guided photo/TRAIL synergistic cancer therapy. Biomaterials. 176. 60–70. 41 indexed citations
20.
Shi, Yesi, Xin Pang, Junqing Wang, & Gang Liu. (2018). NanoTRAIL‐Oncology: A Strategic Approach in Cancer Research and Therapy. Advanced Healthcare Materials. 7(11). e1800053–e1800053. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026